All Posts

Healthcare leaders broadly agree on the direction of value-based care. Payment models are steadily shifting away from volume and toward accountability for outcomes. Programs across Medicare Advantage, ACO REACH, and emerging initiatives such as ACCESS increasingly expect organizations to demonstrate measurable improvement in health status over time. Yet a structural problem sits beneath this transition. Healthcare organizations are being asked to demonstrate outcomes they oft

Medicare Advantage operations 2026 will look fundamentally different from the prior decade. Enrollment growth has slowed to roughly 3 percent, reaching approximately 35.5 million beneficiaries. At the same time, more than 80 percent of that net growth is concentrated in Special Needs Plans, particularly Dual Eligible SNPs and Chronic Condition SNPs. Broad-based MA expansion has plateaued. Complexity has not. CMS is simultaneously tightening payment accuracy rules and refining

The CMS ACCESS Model is being described in many circles as a chronic care innovation. That framing is incomplete. Viewed in isolation, ACCESS looks like a voluntary model designed to improve management of hypertension, diabetes, musculoskeletal conditions, and behavioral health through technology enabled care. Viewed in context of recent rate releases, risk adjustment tightening, and encounter validation pressure, it becomes something more consequential. The CMS ACCESS Model

Introduction: Flat Is Not Neutral Over the past week, industry reaction to CMS policy headlines has converged around one phrase: flat rates. The CMS CY 2027 Advance Notice, combined with ongoing Medicare Advantage recalibration and tightening of risk adjustment, has been widely interpreted as signaling a cooling cycle. A pause. A holding pattern. That interpretation is wrong. Flat rates are not neutral. They are pressure. CMS flat Medicare Advantage rates are not about budget

Introduction: This Is Not a Coding Change. It Is a Care Model Reckoning. The CMS CY 2027 Advance Notice is being framed in many circles as a technical recalibration of Medicare Advantage risk adjustment. That interpretation misses the signal. By proposing to exclude diagnoses captured through unlinked chart reviews and requiring that conditions be supported by encounter-based claims, CMS is not simply tightening payment accuracy. It is redefining what counts as real, auditabl